Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Doctors Dance Wearing PPE Kits: COVID-19 | BOOM

How are doctors keeping sane through the incredible pressure of working in PPE kits due to #COVID19? By dancing! Recently, ENT Surgeon Dr Arup Senapati was in the news for his dance on an Hrithik Roshan song. He tells BOOM what motivated him to do so.
Watch this video to see how doctors dancing in PPE Kits became a global phenomenon through the toughest moments of battling with the novel coronavirus, COVID-19.

Kerala doctor couple designs risk calculator for breast cancer 

A doctor couple in Kerala, Dr. Regi Jose and Dr Paul Augustine along with some others has developed a tool that may be able to assess the risk of a woman to develop breast cancer.
The risk calculator works by providing a score when the person answers a list of 7 questions. It may help women determine the frequency and kind of medical screening they need in order to get diagnosed in time.
To develop the calculator, they used statistical modelling after trying out various methods like the Gail method. Depending on the score, the person will know how often they need to undergo screening.
The calculator takes into account factors like age, history of breast feeding, age at menarche among other parameters.

A doctor couple in Kerala, Dr. Regi Jose and Dr Paul Augustine along with some others developed a tool that may be able to assess the risk of breast cancer in a woman.
The risk calculator works by providing a score when the person answers a list of 7 questions. It may help women determine the frequency and kind of medical screening they need in order to get diagnosed in time.
To develop the calculator, they used statistical modelling.&nbsp;The calculator takes into account factors like age, history of breast feeding, age at menarche among other parameters.

Study: spike in pollution can cause a surge of 8-9% Covid cases 

In an interview to India Today, AIIMS Director Dr&nbsp;Randeep Guleria said that even a slight increase in pollution will increase the coronavirus cases in the country. A Lancet study has shown that even a little bit of increase in PM 2.5 levels lead to a surge of at least 8-9% increase in Covid cases. Data also suggests that India has two peak seasons for influenza-like-illnesses, one being monsoon and the other being winter, since&nbsp;Covid-19 is a respiratory viral infection behaves almost like influenza. Dr Guleria cautioned against crowding and carelessness and said that wearing a mask, practicing physical distance and hand hygiene could reduce the cases by at least 30-40%.

Slightest increase in pollution&nbsp;can cause spike in Covid cases
AIIMS&nbsp;Director: increase in PM 2.5 levels will cause surge
Winter &amp; monsoon peak seasons for influenza like illnesses&nbsp;
Dr Randeep&nbsp;Guleria&nbsp;cautions against crowding, carelessness&nbsp;
Wearing masks, social distancing will reduce cases by 30-40%
&nbsp;

In an interview to India Today, AIIMS Director Dr&nbsp;Randeep Guleria said that even a slight increase in pollution will increase the coronavirus cases in the country. A Lancet study has shown that even a little bit of increase in PM 2.5 levels lead to a surge of at least 8-9% increase in Covid cases. Data also suggests that India has two peak seasons for influenza-like-illnesses, one being monsoon and the other being winter, since&nbsp;Covid-19 is a respiratory viral infection behaves almost like influenza. Dr Guleria cautioned against crowding and carelessness and said that wearing a mask, practicing physical distance and hand hygiene could reduce the cases by at least 30-40%.

'Don't be afraid of Covid': Trump is out of hospital

US President Donald Trump returned to the White House on Monday night after spending four days at a military hospital where he was treated for coronavirus

Trump returns to White House after 4-day stay at hospital

US President Donald Trump returned to the White House on Monday night after spending four days at a military hospital where he was treated for coronavirus. The 74-yr-old looked healthy. Showing his fitness, Trump in an unusual decision climbed up the South Portico stairs, instead of the elevators, to go to his residence, reports said. Moments before leaving the Walter Reed National Medical Center, Trump hit out at the polls showing him behind his rival Joe Biden with just weeks left for November election. &ldquo;Will be back on the Campaign Trail soon!!! The Fake News only shows the Fake Polls,&rdquo; Trump tweeted.

Washington, PTI: US President Donald Trump returned to the White House Monday night after spending four days at a military hospital where he was treated for coronavirus.
Trump, 74, looked healthy. Showing his fitness, Trump in an unusual decision climbed up the South Portico stairs, instead of the elevators, to go to his residence. He waived at reporters.
The president, after taking off his mask, stood up in the portico facing South Lawns for a few minutes and saluted Marine One.
Earlier, he was discharged from the Walter Reed National Medical Center after doctors treating him found that he was fit enough to go back home.
&ldquo;Will be back on the Campaign Trail soon!!! The Fake News only shows the Fake Polls,&rdquo; Trump said in a tweet moments before leaving Walter Reed National Medical Center in Bethesda, a Maryland suburb of Washington DC.
His former White House Press Secretary Sarah Sanders said the president was strong and upbeat.
&ldquo;He&rsquo;s a fighter and will not quit battling this virus or surrender to the liberal mob and forces out to destroy our country,&rdquo; Sanders said in a tweet.
Before boarding Marine One at Walter Reed, Trump told reporters that he was feeling good.
White House physician Dr Sean Conley told reporters at the Walter Reed National Military Center, Trump has exceeded all standard hospital discharge criteria and has received another dose of remdesivir drug in his treatment of COVID19.
&ldquo;Over the past 24 hours, the president has continued to improve. He's met or exceeded all standard hospital discharge criteria. He has received another dose of remdesivir you're here today, and then we plan to get him home,&rdquo; he said.
&ldquo;It's been more than 72 hours since his last fever. Oxygen levels, including ambulatory saturations and his work of breathing or all normal though. He may not entirely be out of the woods, yet the team and I agree that all our evaluations and most importantly, his clinical status support the president's safe return home, where he'll be surrounded by world-class medical care 24 seven,&rdquo; Dr Conley said.
Dr Sean Dooley, a pulmonary critical care physician, told reporters that the president continues to do very well.
His vital signs this morning, temperature was 98.1, his blood pressure 134 and 78 and respiratory rate 17 per minute. His heart rate was 68 beats per minute and his last Oxo hemoglobin saturation was 97 per cent on room air, he said.
He currently does not endorse any respiratory complaints, the physician said.
According to Dr Brian Garibaldi, director of Johns Hopkins Biocontainment Unit, on Sunday evening, the president received his third dose of remdesivir and he tolerated that infusion without difficulty.
His kidney and liver function continued to be normal, he said.

Hathras case: CMO rubbishes 'no rape' FSL report 

The Chief Medical Officer of AMU&rsquo;s JN Medical College, where the 19-year-old Hathras victim was admitted for two weeks, has rubbished the FSL report that said "no rape"

The Chief Medical Officer of AMU&rsquo;s JN Medical College, where the 19-year-old Hathras victim was admitted for two weeks, has rubbished the FSL report that said "no rape", The Indian Express has reported. The UP Police had relied on this report to claim that the woman was not raped. CMO Dr Azeem Malik told The Indian Express that the samples were collected 11 days after the woman was allegedly raped, while government guidelines strictly say forensic evidence can only be found up to 96 hours after the incident. "This report can&rsquo;t confirm rape in this incident,&rdquo; Dr Malik stated.

'Coronavirus made in China lab, WHO part of cover-up'

Chinese virologist Dr Li-Meng Yan has claimed that the deadly coronavirus was developed in a government laboratory in Wuhan, and WHO is a part of the&nbsp;cover-up

Chinese virologist Dr Li-Meng Yan has claimed that the deadly coronavirus was developed in a government laboratory in Wuhan. In an interview to news channel Wion, Dr Yan, who investigated the origin of the COVID-19 virus during the initial outbreak in Wuhan, has claimed that Chinese government knew about the spread of the virus before publicly acknowledging it. According to Dr Yan the World Health Organization is very much a part of the cover up. She has also alleged that the Chinese government is now trying to tarnish her reputation and is also threatening her family in China

Chinese virologist Dr Li-Meng Yan has claimed that the deadly coronavirus was developed in a government laboratory in Wuhan. In an interview to news channel Wion, Dr Yan, who investigated the origin of the Covid-19 virus during the initial outbreak in Wuhan, has claimed that the Chinese government knew about the spread of the virus before publicly acknowledging it. According to Dr Yan the World Health Organization is very much a part of the cover up. She has also alleged that the Chinese government is now trying to tarnish her reputation and is also threatening her family in China

'382 docs died of Covid': IMA slams Centre for 'abandoning heroes'

"Why call them corona warriors, if...": The Indian Medical Association has accused the central govt of indifference towards the doctors who have died while treating Covid-19 patients.

The Indian Medical Association has accused the central govt of indifference towards the doctors who have died while treating Covid-19 patients. Peeved at health minister Dr Harshavadhan's statement on coronavirus in parliament, which had no word on the doctors who died in the line of duty, and his junior minister's statement that the Centre had no data as health is a state subject, the IMA has said that the Centre has abandoned the heroes. In a strong statement, the medical body has stated that so far, 382 doctors have died of coronavirus. But the health minister made no mention of the medical professionals lost to the disease, the IMA said. This exposes the "hypocrisy of calling them corona warriors on one hand and denying them and their families the status and benefits of martyrdom," the IMA stated.

The Indian Medical Association has slammed the central govt accusing it of indifference towards the doctors who have died while treating Covid-19 patients. Peeved at health minister Dr Harshavadhan's statement on coronavirus in parliament, which had no word on the doctors who died in the line of duty, and his junior minister's statement that the Centre had no data as health is a state subject, the IMA has said that the Centre has abandoned the heroes. In a strong statement, the medical body has stated that so far, 382 doctors have died of coronavirus. In the list it released, the youngest doctor to lose his life was 27 years old and the oldest was 85. has infuriated. But the health minister made no mention of the medical professionals lost to the disease, the IMA said. This exposes the "hypocrisy of calling them corona warriors on one hand and denying them and their families the status and benefits of martyrdom," the IMA said.

Dr Rasool Latifi - transforming Jammu one vertical garden at a time

Say hello to Dr. Nazia Rasool Latifi, an environmentalist doing her bit to enhance the green cover in Jammu.
Using plastic bottles Dr. Latifi creates vertical gardens in different spaces of the city. They not only enhance greenery but also help in the management of waste bottles, add beauty to any space and help conserve water because they make use of the drip irrigation method.
This also works really well in areas with space constraint, and helps counter the negative impacts of noise and air pollution Dr. Latifi says.
She made the vertical garden in the Government College for women Gandhi Nagar where she was teaching and the Police Public School. She's hand-picked the plants, to include chlorophytum, syngonium and others so they can tackle pollution and survive in extreme weather conditions.

Dr Rasool Latifi, transforming Jammu one vertical garden at a time

Say hello to Dr. Nazia Rasool Latifi, an environmentalist doing her bit to enhance the green cover in Jammu.
Using plastic bottles Dr. Latifi creates vertical gardens in different spaces of the city. They not only enhance greenery but also help in the managing waste bottles, add beauty to any space and help conserve water as they make use of the drip irrigation method.
This also works really well in areas with space constraint, and helps counter the negative impacts of noise and air pollution Dr. Latifi says.
She has made a vertical garden in the Government College for women Gandhi Nagar where she taught and the Police Public School. She's hand-picked the plants, to include chlorophytum, syngonium and others so they can tackle pollution and survive in extreme weather conditions.

Serum Institute gets nod to resume Covid vaccine trials

Drugs Controller General of India on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford Covid-19 vaccine candidate

Drugs Controller General of India on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford Covid-19 vaccine candidate. The DCGI, Dr V G Somani, has however, put certain conditions like taking extra care during screening, providing additional information in informed consent to be followed during the trials. The DCGI had on September 11 directed Serum Institute of India to suspend any new recruitment in the phase two and three clinical trial of the Oxford Covid-19 vaccine in the backdrop of pharma giant AstraZeneca pausing the clinical trials in other countries because of "an unexplained illness" in a volunteer.

New Delhi, PTI: Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford Covid-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial.
The DCGI, however, put certain conditions like taking extra care during screening, providing additional information in informed consent and close monitoring for adverse events during follow-up of the study which have to be "scrupulously" followed by Serum Institute of India (SII).
SII has also been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events.
The DCGI had on September 11 directed Serum Institute of India to suspend any new recruitment in the phase two and three clinical trial of the Oxford Covid-19 vaccine candidate till further orders in the backdrop of pharma giant AstraZeneca pausing the clinical trials in other countries because of ''an unexplained illness'' in a participant in the study.
On Saturday, British-Swedish biopharmaceutical giant AstraZeneca and the University of Oxford said clinical trials for their coronavirus vaccine have resumed in the UK after the Medicines Health Regulatory Authority's (MHRA) confirmed that the trials were safe.
SII, which has partnered with AstraZeneca for manufacturing the vaccine candidate for Covid-19, on Tuesday submitted the recommendations of the Data and Safety Monitoring Board (DSMB), UK and DSMB, India, and requested for permission to restart enrolment in the clinical trial.
According to Tuesday's order issued by DCGI, the DSMB, UK, recommended that the investigators recommence all immunization in their clinical trials subject to certain conditions.
DSMB, India, also has recommended to continue the study and enroll the remaining participants in the clinical trial as per protocol subject to certain conditions.
According to the order, SII has submitted revised participant information sheet, revised informed consent form and additional safety monitoring plan for the evolved participants.

Serum India told to halt recruitment for vaccine trials

India's drug regulator has directed Serum Institute of India to suspend recruitment of new volunteers for phase 2 and 3 clinical trials of the Oxford Covid-19 vaccine candidate

India's drug regulator has directed Serum Institute of India to suspend recruitment of new volunteers for phase 2 and 3 clinical trials of the Oxford Covid-19 vaccine candidate. The directive came in the backdrop of pharma giant AstraZeneca pausing the trials in other countries. The DCGI on Friday also directed Serum Institute to increase the safety monitoring of the subjects already vaccinated as part of the trial, and submit the plan and report. The drugmaker&nbsp;had on Thursday hit a pause after AstraZeneca put the trials on hold following an unexplained illness in a volunteer in the UK.

New Delhi, PTI: Drugs Controller General of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford Covid-19 vaccine candidate in the backdrop of pharma giant AstraZeneca pausing the trials in other countries.
In an order, a copy of which has been accessed by PTI, DCGI Dr V G Somani on Friday also directed Serum Institute of India (SII) to increase the safety monitoring of the subjects already vaccinated as part of the trial, and submit the plan and report.
Somani also asked the firm to submit clearance from Data and Safety Monitoring Board (DSMB) in the UK as well as in India to obtain clearance from his office (DCGI) prior to resumption of future recruitment in the trial. The central drug regulator DCGI had issued a show-cause notice to SII on September 9 for not informing it about AstraZeneca pausing clinical trials of the vaccine candidate in other countries and also for not submitting casualty analysis of the "reported serious adverse events".
Following which the Pune-based firm, which has partnered with the British-Swedish biopharmaceutical giant AstraZeneca for manufacturing the Oxford vaccine candidate, on Thursday said it is pausing the clinical trials in India.
Earlier this week, AstraZeneca said it had paused the trials because of 'an unexplained illness' in a participant in the study. "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials," SII said in a statement on Thursday. According to the DCGI's order issued on Friday, the SII in its reply stated that DSMB has noted no safety concerns from the Indian study (part 1-phase-2 study) with the first dose and seven days post vaccination safety data. In its reply, SII also stated that DSMB further recommended "to pause further enrolment into the study until ongoing investigations of SAE reported in the UK study is completed and the sponsor and the UK DSMB are satisfied that it doesn't pose any safety concerns".
"In the view of the above, I Dr V G Somani, Drugs Controller General of India, Central Licensing Authority, after careful examination of your reply and the recommendations of the DSMB in India, in exercise of the powers vested under Rule 30 of the New Drugs and Clinical Trials Rules, 2019, direct to you suspend any new recruitment in the phase 2 and 3 clinical trial till further orders," the order read.
"Increase the safety monitoring of the subjects already vaccinated with the vaccine under trial and submit the plan and report," the order further stated.

Is the pause in the Oxford vaccine trial a setback? | BOOM

AstraZeneca recently paused clinical trials for the Covid-19 vaccine after a patient experienced a neurological malfunction symptoms with a rare but serious spinal cord disorder. What does this mean for the race to finding a coronavirus vaccine where the Oxford vaccine was a global frontrunner? What questions does this raise on vaccine trials and their efficacy as well? BOOM Explains.
Dr. N.Kumarasamy, Chief &amp; Director, VHS-Infectious Diseases Medical Centre says that more than 100 different vaccines are in various levels of clinical trials globally right now to fight the novel coronavirus, #COVID19. A strict inclusion criteria to onboard patients for #vaccinetrials is that the patient must be disease free, so that they can be monitored properly if they develop health issues.
In case of the #Astrazeneca trial, we need to wait for more evidence to know if the neurological side effect in the patient is related to the vaccine or other conditions before we move forward with the trials. This will also cause serious concern among trial participants from being included in future trials so we need transparency in process just like regulators have rightly done with Oxford vaccine trials.
Watch BOOM's Govindraj Ethiraj interview Dr N. Kumarasamy on the various stages of vaccine development and how adverse events i.e. side effects on patients are recorded while developing vaccines across the world.

dr

Categories